Sugarcane extract prevents inflammation neurodegeneration
Australian food flavors and ingredients manufacturer The Product Maker (TPM) recently stated that the company's polyphenol-rich sugar cane extract can relieve oxidative stress, inflammation and neurodegeneration.
Researchers conducted preclinical studies on the company's patented ingredient Polynol and found that this sugarcane extract exhibited anti-inflammatory effects in human cell cultures.
The accumulation of reactive oxygen species leads to oxidative stress, which can easily lead to neurodegenerative diseases, such as Parkinson's disease and Alzheimer's disease, and other neurological disorders such as anxiety and depression.
Our brain contains a lot of polyvalent unsaturated fatty acids, which are prone to peroxidation, and there are not enough antioxidants to protect the brain. Polynol can disrupt the path and reshape the body's oxidative balance.
The researchers explained that Polynol’s anti-inflammatory properties may be due to its ability to inhibit the pro-inflammatory cytokine TNF-α and activate the Nrf2-ARE transduction pathway. Polynol can maintain the integrity of neuronal DNA, thereby preventing neuronal cells from oxidative stress. In addition, it can also prevent neurodegenerative diseases by regulating key proteins such as monoamine oxidase (MAO).
Dr. Barry Kitchen, head of TPM's Bioactives Business Unit, said: "This clinical discovery is a major breakthrough in the use of natural plant extracts to therapeutically intervene and regulate brain oxidative stress, inflammation and other neurological disorders."
The research was published in PharmaNutriton.
2026-10-11
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Vietnam: Sustainable measures proposed for sweet sugarcane season
-
New food raw material sugarcane extract and Bifidobacterium longum subspecies BB536 open for comments
-
"Zipper-Like" Opening and Closing of Hormuz Coupled with Russian Export Ban Send Energy and Chemical Prices Soaring
-
India Strengthens Drug Approval Oversight with Expanded CDSCO Powers
-
Germany Passes Healthcare Reform, Multinational Drugmakers Face 15.5% Mandatory Discount
-
When SWIFT Goes On-Chain: A New 24/7 Order for Cross-Border Payments
-
Middle East Conflict Exposes Fragility of Global Fertilizer Supply Chains
-
From Painting Walls to Total Collapse: The RMB 152 Million Debt That Tore Off the Last Veil of Asia Chuangneng’s Paint Empire
-
Moldova Proposes Stricter Quality Standards for Edible Casein and Caseinates
-
FDA Dye Phase-Out Push Opens a Bigger Window for Natural Color Solutions
Recommend Reading
-
U.S. API Dependence Turns Pharmaceutical Ingredients Into a National Security Issue
-
Glyphosate Faces New UK Pressure as EU Trade Alignment Returns to the Debate
-
Retinol in Cosmetics: Regulatory Tightening and Market Changes
-
Pharma Tariff Risk Pushes Global Drugmakers to Rebuild U.S. Supply Chains
-
“Zero Tariff Is Not a Get-Out-of-Jail-Free Card”: Hainan’s Full Customs Closure—Boon or Trap for the Chemical Industry?
-
FDA Names Veteran Oncology Regulator Pazdur as Director of Drug Review Center
-
Polyester Bottle Flakes Market Shows Strong Upward Trend in Recent Two Days
-
Vera’s New Kidney Drug Wins FDA Approval, Carrying a $425,000 Annual Price
-
Insufficient Cost and Demand Support; PTA Prices to Weaken
-
Recent Weak Performance of Dichloromethane